Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | MARS PHARMACEUTICAL DISTRIBUTORSLikely | Evaluation in Progress | 3 | ₹15.12 |
| 2 | Schedule 2 | MARS PHARMACEUTICAL DISTRIBUTORSLikely | Evaluation in Progress | 2 | ₹2,730 |
| 3 | Schedule 3 | MARS PHARMACEUTICAL DISTRIBUTORSLikely | Evaluation in Progress | 2 | ₹51.98 |
| 4 | Schedule 4 | MARS PHARMACEUTICAL DISTRIBUTORSLikely | Evaluation in Progress | 2 | ₹24.26 |
| 5 | Schedule 5 | MARS PHARMACEUTICAL DISTRIBUTORSLikely | Evaluation in Progress | 2 | ₹38.12 |
Tender Value
₹5.3 L
EMD Value
Exempted
Closing Date
22 May 2025, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tab Capecitabine
Inj Liposomal Doxorubicin
Inj Cyclophosphamide
Inj Doxorubicin
Inj Epirubicin
Tab Temozolomide
InjBortezomab
Inj Mesna
InjBevicizumab
InjIfophosphamide
InjTrastuzumab
InjTrastuzumab Emtansine
Tab Lapatinib
Tab Tamoxifen
Tab Everolimus
InjEribulin
InjAdotrastuzumab
Tab Letrozole
Tab Palbociclib
Tab Anastrozole
InjLeuprolideAsetate
InjOxaliPlatin
Inj 5FU
Inj CLV
Inj Paclitaxel
InjNabpaclitaxel
Inj Carboplatin
Inj Cetuximab
InjIrinotecan
Tab Regrofinab
InjPembrolizumab
InjCisplatin
InjVinorelbine
Egorelis
InjDocetaxel
InjGemicitabine
Tab Erilotinib
InjPemetrexed
Tab Gefitinib
Inj Vincristine
Inj Vinblastine
Tab Remivin
InjFulvestrant
Tab Ribociclib
Tab Olapariv
Tab Enzalutamide
InjTriptoline
Tab Biclutamide
Tab Abireterone
InjDegorelis
InjMitomycin
Tab Rucaparib
InjBleomycin
InjRitozumab
InjDacarabazine
InjDenosumab
Inj Albumin
InjOcteotrideLar
InjZoldronic Acid
Apricap Kit
InjPalonsetron
Inj Graffil
InjRomiplastin
InjAlamin
Tab Megestrol
Protein Powder
Tab Sunitib
Tab Lorlatinib
Inj Durvalumab
7792675
GEM/2025/B/6187904
Two Packet Bid
Tab Capecitabine
15 days
Tariq Jan190003Rainawari
Item wise evaluation
BOQ
6 documents required · 6 mandatory
2 yrs
₹3
10%
Exempted
22 May 2025
30 Apr 2025
22 May 2025
Tab Capecitabine
Inj Liposomal Doxorubicin
Inj Cyclophosphamide
Inj Doxorubicin
Tab Temozolomide
InjIfophosphamide
InjTrastuzumab Emtansine
InjAdotrastuzumab
Tab Palbociclib
Tab Anastrozole
InjLeuprolideAsetate
InjNabpaclitaxel
Inj Carboplatin
InjPembrolizumab
InjGemicitabine
Inj Vincristine
Inj Vinblastine
Tab Enzalutamide
Tab Biclutamide
Tab Abireterone
InjDacarabazine
InjOcteotrideLar
InjZoldronic Acid
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7792675.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
doc_29-04-2025_2025-04-30-21-28-11_8c8810d110628d2be92f9a17f12906bf.pdf
BOQ
chemo_2025-04-30-21-28-11_46175ff0b5312983dbfd40ab4937fdc7.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .